相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients
Daniel J. Firl et al.
HEPATOLOGY (2020)
Identification of an Upper Limit of Tumor Burden for Downstaging in Candidates with Hepatocellular Cancer Waiting for Liver Transplantation: A West-East Collaborative Effort
Quirino Lai et al.
CANCERS (2020)
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant
Alessandro Cucchetti et al.
JOURNAL OF HEPATOLOGY (2020)
Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference
Marina Berenguer et al.
TRANSPLANTATION (2020)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Validation of the -fetoprotein Model for Hepatocellular Carcinoma Recurrence After Transplantation in an Asian Population
Jinsoo Rhu et al.
TRANSPLANTATION (2018)
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
Andrea Notarpaolo et al.
JOURNAL OF HEPATOLOGY (2017)
Recurrence After Liver Transplantation for Hepatocellular Carcinoma A New MORAL to the Story
Karim J. Halazun et al.
ANNALS OF SURGERY (2017)
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Sarah Berhane et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America
Federico Pinero et al.
LIVER INTERNATIONAL (2016)
Concordance for prognostic models with competing risks
Marcel Wolbers et al.
BIOSTATISTICS (2014)
Net Reclassification Indices for Evaluating Risk Prediction Instruments A Critical Review
Kathleen F. Kerr et al.
EPIDEMIOLOGY (2014)
Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate
Matteo Cescon et al.
JOURNAL OF HEPATOLOGY (2013)
The Use and Interpretation of Competing Risks Regression Models
James J. Dignam et al.
CLINICAL CANCER RESEARCH (2012)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux et al.
GASTROENTEROLOGY (2012)
Tools for Monitoring Patients With Hepatocellular Carcinoma on the Waiting List and After Liver Transplantation
Norman Kneteman et al.
LIVER TRANSPLANTATION (2011)
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2011)
Comparing the predictive powers of survival models using Harrell's C or Somers' D
Roger B. Newson
STATA JOURNAL (2010)
Validation, updating and impact of clinical prediction rules: A review
D. B. Toll et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)
分享论文
